SurvivorHealthcare
What Happened to Tevogen Bio Holdings?
Ticker: TVGNSPAC Year: 2021
Return
-44.5%
Current Price
$5.55
Peak Price
$1054.5
Trust Size
$4M
Summary
Tevogen Bio is a clinical-stage biopharmaceutical company developing T-cell therapies for infectious diseases and cancer using its proprietary ExacTcell platform.
What Happened
Tevogen Bio went public through a SPAC merger and trades under TVGN. The company's ExacTcell platform produces precise T-cell therapies that can be manufactured and stored as off-the-shelf treatments. The company has attracted attention for its approach to T-cell therapy but remains early-stage with limited clinical data.
Timeline
2021-10-22
S-1 Registration Filed
Risk Indicators
⚠️ Reverse Split